Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-25-001545

← back to feed
Filed
Oct 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 24, 2025 10.98M sh
Shares Diluted Q3 2025 · Sep 30, 2025 10.98M sh
Shares Diluted Q3 2025 · Sep 30, 2025 11.4M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 10.89M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 10.81M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $272.87K
Operating Cash Flow Q3 2025 · Sep 30, 2024 $73.49K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.14M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $662.52K
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.71M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.72M
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.26M
Stockholders Equity Q3 2025 · Dec 31, 2024 $835.24K
Stockholders Equity Q3 2025 · Sep 30, 2024 $370.28K
Stockholders Equity Q3 2025 · Jun 30, 2024 $189.08K
Stockholders Equity Q3 2025 · Mar 31, 2024 $114.86K
Stockholders Equity Q3 2025 · Dec 31, 2023 −$6.76K
Total Liabilities Q3 2025 · Sep 30, 2025 $356.14K
Total Liabilities Q3 2025 · Dec 31, 2024 $38.55K
Current Assets Q3 2025 · Sep 30, 2025 $1.99M
Current Assets Q3 2025 · Dec 31, 2024 $847.75K
Total Assets Q3 2025 · Sep 30, 2025 $2.07M
Total Assets Q3 2025 · Dec 31, 2024 $873.79K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.08
Eps Diluted restated Q3 2025 · Sep 30, 2024 $0.01
Eps Diluted restated Q3 2025 · Sep 30, 2024 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 $0.08
Eps Basic restated Q3 2025 · Sep 30, 2024 $0.01
Eps Basic restated Q3 2025 · Sep 30, 2024 $0.01
Sga Expense Q3 2025 · Sep 30, 2025 $576.66K
Sga Expense Q3 2025 · Sep 30, 2025 $1.55M
Sga Expense Q3 2025 · Sep 30, 2024 $345.29K
Sga Expense Q3 2025 · Sep 30, 2024 $846.24K
Rd Expense Q3 2025 · Sep 30, 2025 $66.37K
Rd Expense Q3 2025 · Sep 30, 2024 $29.81K
Net Income Q3 2025 · Sep 30, 2025 −$8.78K
Net Income Q3 2025 · Sep 30, 2025 $875.72K
Net Income Q3 2025 · Jun 30, 2025 $457.7K
Net Income Q3 2025 · Mar 31, 2025 $426.8K
Net Income Q3 2025 · Sep 30, 2024 $56.2K
Net Income Q3 2025 · Sep 30, 2024 $77.04K
Net Income Q3 2025 · Jun 30, 2024 $74.22K
Net Income Q3 2025 · Mar 31, 2024 −$53.38K
Operating Income Q3 2025 · Sep 30, 2025 −$8.78K
Operating Income Q3 2025 · Sep 30, 2025 $875.72K
Operating Income Q3 2025 · Sep 30, 2024 $56.2K
Operating Income Q3 2025 · Sep 30, 2024 $77.04K
Gross Profit Q3 2025 · Sep 30, 2025 $698.23K
Gross Profit Q3 2025 · Sep 30, 2025 $2.67M
Gross Profit Q3 2025 · Sep 30, 2024 $424.74K
Gross Profit Q3 2025 · Sep 30, 2024 $969.88K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $433.2K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.45M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $148.23K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $264.87K
Revenue Q3 2025 · Sep 30, 2025 $1.13M
Revenue Q3 2025 · Sep 30, 2025 $4.12M
Revenue Q3 2025 · Sep 30, 2024 $572.97K
Revenue Q3 2025 · Sep 30, 2024 $1.23M